Rabeprazole sodium, a potent antisecretory compound, selectively inhibits gastric acid secretion by targeting the H+ and K+ ATPase at the surface of gastric parietal cells. It has demonstrated ...

March 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for rabeprazole sodium 20-mg delayed-release tablets and ranitidine HCl 15-mg/mL oral ...

Akums Drugs & Pharmaceuticals Ltd., one of the country’s largest India-CDMO serving the Indian domestic pharmaceutical industry, has announced the launch of Rabeprazole + Levosulpiride SR Capsules.

Rabeprazole (RABIDOR-LSR) is a proton pump inhibitor, prescribed for duodenal ulcer, gastro esophageal reflux disease (GERD), and Zollinger-Ellison (gastric acid hyper secretion) syndrome. It works by ...

PO- Gastro-oesophageal reflux disease; erosive oesophagitis: 20 mg once daily in the morning for 4-8 weeks. Maintenance: 10-20 mg once daily. For non-erosive oesophagitis: 10 mg once daily for 4 wk, ...

The US Food and Drug Administration (FDA) has approved the first generic versions of Aciphex (rabeprazole sodium; Eisai) delayed-release tablets for the treatment of gastroesophageal reflux disease ...

This leaflet answers some common questions about RABEPRAZOLE MYLAN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...

Co announces that the FDA has granted final approval for the Company's Abbreviated New Drug Application for Rabeprazole Sodium Delayed-Release Tablets, 20 mg. TEVA's Rabeprazole Sodium Delayed-Release ...